Document Detail

Myocardial Gi alpha-protein levels in patients with hypertensive cardiac hypertrophy, ischemic heart disease and cardiogenic shock.
MedLine Citation:
PMID:  8575009     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Increased inhibitory G-protein alpha-subunits (Gi alpha) have been reported to be related to adenylyl cyclase desensitization in the failing human heart. In order to investigate whether this cellular alteration occurs already at the stage of hypertensive cardiac hypertrophy or in catecholamine-refractory cardiogenic shock, Gi alpha levels were studied in myocardial samples from patients with hypertensive cardiac hypertrophy, coronary heart disease without heart failure and from patients with cardiogenic shock on high-dose catecholamine therapy as well as from patients without evidence of heart disease. METHODS: Gi alpha was quantified with pertussis-toxin-catalyzed 32P-ADP-ribosylation and with a radioimmunoassay in myocardial samples from patients within 16 h of death. The radioimmunoassay was constructed with recombinant G-protein alpha-subunits (rGi alpha 1) from transformed E. coli harbouring the full-length cDNA of Gi alpha 1, iodinated peptide 125I-KENLKDCGLF and immunoprecipitating antiserum (MB 1) raised against the synthetic peptide (KENLKDCGLF) in rabbits. RESULTS: Pertussis toxin substrates and immunochemical Gi alpha remained stable up to 80 h following storage at room temperature in myocardium obtained during cardiac transplantation. Gs alpha, adenylyl cyclase, beta-adrenoceptors and inhibitory receptors were not stable and could not be determined. Increases in myocardial Gi alpha of 65-82% of both pertussis toxin substrates and immunologically quantified Gi alpha were observed in hypertensive cardiac hypertrophy. Catecholamine therapy in patients who died of catecholamine-refractory shock increased myocardial Gi alpha by 225% compared to myocardium from patients with coronary heart disease without heart failure and without catecholamine therapy or compared to control myocardium. CONCLUSION: These findings provide evidence than an increase in myocardial Gi alpha-proteins could be of relevance in pathological conditions other than chronic heart failure. Since an increase in Gi alpha levels already occurs in hypertensive cardiac hypertrophy, it could play a role in contributing to the development of contractile dysfunction and heart failure in later stages of the syndrome. Finally, an increase in Gi alpha could be one mechanism contributing to catecholamine refractoriness in shock. This could provide a target for pharmacological treatment in this condition.
M Böhm; R Kirchmayr; E Erdmann
Related Documents :
300989 - Treatment of cardiogenic shock in myocardial infarction by intraaortic balloon counterp...
23220989 - Acute myocardial infarction caused by spontaneous coronary intramural hematoma.
3421879 - A case of cardiovascular collapse due to adrenal insufficiency.
2393609 - Measurement of cardiac reserve in cardiogenic shock: implications for prognosis and man...
20571889 - Sepsis-induced cardiomyopathy: a review of pathophysiologic mechanisms.
8059489 - Biological effects of shock waves: induction of arrhythmia in piglet hearts.
16918379 - Antithrombotic therapy.
445759 - Noninvasive recording of his-purkinje activity in patients with complete atrioventricul...
17554629 - Hdl and its sphingosine-1-phosphate content in cardioprotection.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cardiovascular research     Volume:  30     ISSN:  0008-6363     ISO Abbreviation:  Cardiovasc. Res.     Publication Date:  1995 Oct 
Date Detail:
Created Date:  1996-03-14     Completed Date:  1996-03-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0077427     Medline TA:  Cardiovasc Res     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  611-8     Citation Subset:  IM    
Klinik Ill für Innere Medizin, Universität zu Köln, Cologne, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blotting, Western
Cardiomegaly / metabolism
GTP-Binding Proteins / metabolism*
Heart Diseases / metabolism*
Hypertension / metabolism
Myocardial Ischemia / metabolism
Myocardium / metabolism*
Shock, Cardiogenic / metabolism
Time Factors
Reg. No./Substance:
EC 3.6.1.-/GTP-Binding Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Alterations in G-protein-regulated transmembrane signalling induced in murine myocardium by coxsacki...
Next Document:  Lazaroids and deferoxamine attenuate the intracellular effects of oxyhaemoglobin in vascular smooth ...